Cannabis Venture Capital: How to Attract Investment in a Growing Industry

Daniel Olmedo Nieto | Co-Founder @ EasyVC | Forbes 30 Under 30 Europe
The cannabis industry has transformed from a niche market into one of the fastest-growing sectors in North America and beyond. In 2023 alone, global cannabis sales reached over $51 billion, up nearly 50% from just three years prior. This explosive growth is catching the eye of venture capitalists looking to back the next big thing in cannabis tech, cultivation, retail, and wellness. But attracting venture capital in cannabis isn’t as simple as having a great idea—unique regulations, market volatility, and limited access to traditional funding make it a world of its own. Whether you’re a startup founder or just curious about the industry, understanding what investors are looking for—and how to stand out—can be the difference between blending in or breaking through.

What Makes Cannabis Venture Capital Different?

Cannabis investment operates in a world where innovation collides with legal uncertainties, making it unlike any other venture capital sector. Here, even the simplest business transactions can require creative navigation, and traditional investment playbooks often fall short.

Unlike mainstream industries, cannabis startups and their investors must contend with an ever-changing legal landscape. Laws shift not just from country to country, but from state to state—and sometimes even city to city. Everything from banking access to advertising carries additional scrutiny. Federal illegality in the United States adds a constant risk, limiting institutional investors and sometimes even causing issues like asset seizures or denial of basic business services.

Consumer demand is strong, but market trends in cannabis rarely follow predictable tech or consumer goods curves. Pricing can swing wildly after regulatory changes or harvest shifts. Unlicensed competition, social stigma, and patchwork distribution channels all challenge startups searching for stability. At the same time, winning companies often have to adapt quickly as regulations either open new markets or close old ones overnight.

Investor Profiles and Motivations

Cannabis VC funds are a mix of maverick entrepreneurs, legal specialists, and impact investors—people who thrive on uncertainty and often have personal motivations beyond just financial returns. Many come to the sector because they see an opportunity to shape the early rules of a high-growth industry. Others are driven by the social justice angle: righting the wrongs of prohibition, or increasing access to medical treatments. This blend of optimism, risk tolerance, and activism is uncommon in more mature sectors.

Understanding these differences is essential for anyone looking to bring investors on board. Next, we spotlight trailblazing funds that have defined the cannabis investment landscape—and may just hold the keys to your startup’s next phase of growth.

Top Cannabis Venture Capital Firms in 2024

The cannabis sector has drawn a dedicated tribe of investment funds that understand this industry’s unfiltered realities—navigating regulatory gray zones, cash-heavy operations, and explosive consumer interest. Here’s a look at the most active and impactful cannabis-focused venture capital firms in 2024.

Entourage Effect Capital

Based in California, Entourage Effect Capital homes in on cannabis investments across multiple stages, but with a particular knack for scaling consumer-facing brands. The firm’s portfolio spotlights industry favorites such as Cann and Headset, and their team is known for hands-on operational input, not just writing checks.

Casa Verde Capital

Founded by Snoop Dogg and focused on ancillary services (think tech, logistics, and compliance tools), Casa Verde Capital backs startups that grease the wheels of the cannabis supply chain. Notable bets include Dutchie and Green Bits, vital cogs for retail dispensaries nationwide.

Merida Capital Holdings

Merida Capital’s specialty is finding value at the intersection of cultivation tech, genetics, and supply chain infrastructure. The New York-headquartered firm has taken positions in companies like GrowGeneration and New Frontier Data, staking a claim in both plant-touching and supportive sectors.

Tuatara Capital

Tuatara Capital brings Wall Street savvy to a diverse portfolio—its multistage investment strategy covers cultivation, processing, and sophisticated extraction businesses. Tuatara’s influence can be seen in brands like GTI and BDS Analytics, helping operators get ahead in complex markets.

Gotham Green Partners

Big-ticket growth capital and deep resources set Gotham Green Partners apart. With investments ranging from delivery leader Eaze to vertically integrated Jushi Holdings, Gotham Green isn’t afraid of putting muscle—and sizable funding—behind its convictions.

Altitude Investment Management

Altitude Investment Management casts a wide net across the value chain, including picks in product manufacturing, distribution, and testing. Their portfolio includes BDSA, PathogenDx, and several leading multistate operators, emphasizing scalable infrastructure.

Other Notable Cannabis-Focused Funds

Alongside these frontrunners, other highly active firms include Poseidon Asset Management, The Arcview Group, and Silverleaf Venture Partners. These funds frequently join rounds alongside household names and may bring specialized focus—like sustainability, diversity, or emerging markets in Europe and Latin America.

Connecting with these investors is only the first step—emerging cannabis businesses must also anticipate what these funds look for and how best to present their vision for growth. Let’s get practical and break down what successful fundraising looks like in today’s cannabis venture landscape.

How Cannabis Startups Can Secure Venture Capital

Key Metrics and What Investors Look For

Earning the attention of cannabis venture capitalists takes more than enthusiasm for legalization—you’ll need sharp numbers, crystal-clear strategy, and an understanding of what makes the industry tick. Investors scrutinize monthly recurring revenue, customer acquisition costs, and, critically, your path toward regulatory compliance. If your startup is pre-revenue, VCs will want to see prototypes, letters of intent, or early traction with clear market validation. Don’t shrink from the complexities of the cannabis market; instead, show exactly how you turn challenges like supply chain reliability and state-by-state legal limits into competitive advantages.

Pitching a Cannabis Business

Cannabis investors hear plenty of “we’re the Uber of weed.” Instead, ground your pitch in the realities of the market segment you serve—be it cultivation, distribution tech, retail, or consumer products. Lay out your team’s experience navigating murky compliance waters or developing proprietary technology. Use stories and data to illustrate product-market fit and consumer demand, and highlight partnerships that build credibility. Transparency about risks—like fluctuating regulations or emerging competition—demonstrates you’re prepared for turbulence and have strategies in place to weather it.

Since cannabis remains federally illegal in many areas, traditional banking is complicated. Expect potential investors to probe not just your burn rate, but your approach to basic financial operations. Openly discuss how you manage cash, escrow accounts, payroll services, and safe, fully-audited payment processing. Outline your contingency plans for sudden account closures or banking transitions, and describe how your financial controls mitigate risks unique to the cannabis world. This demonstrates foresight and reduces investor anxiety about operational hiccups.

As you prepare to meet with investors, remember: landing venture capital is only one route to building a cannabis business. Next, we’ll explore alternative funding options that could fit your goals and timeline just as well—or even better—than traditional VC pathways.

Beyond Venture Capital: Alternative Funding Paths

While traditional venture capital can provide substantial support, not every cannabis startup fits neatly into a VC’s mold. Creative entrepreneurs are finding a variety of funding avenues—some with fewer hoops to jump through and more flexible terms.

Angel Investors and Family Offices

Individual backers—especially those drawn to the prospect of being early movers in a still-developing market—play an outsize role in cannabis. Angel investors are often more open to unconventional business models or novel product ideas, while family offices may apply patient capital with a long-term view. Both can bring valuable industry contacts and mentorship, not just money.

Crowdfunding Opportunities

Regulation Crowdfunding now lets cannabis companies tap into grassroots support, raising millions in smaller increments from interested supporters. Platforms like SeedInvest and Republic occasionally host cannabis deals, while niche portals focus exclusively on the industry. This approach turns your community into shareholders and evangelists, but public fundraising also invites scrutiny and extra regulatory compliance.

Debt and Revenue-Based Financing

Bank loans are tough to secure in cannabis, but alternatives are out there. Private lenders and specialty funds provide short- and medium-term loans, typically at higher rates but with less dilution than equity investment. Revenue-based financing—where repayments rise and fall with your monthly income—has gained traction for brands with steady sales but limited tangible assets. This path keeps control in founders’ hands and rewards performance, but it calls for reliable bookkeeping and honest financial projections.

Exploring these diverse funding sources can help cannabis entrepreneurs shape deals on their terms. Of course, staying ahead means more than just finding capital—it requires tuning in to the shifting currents shaping investment in this evolving space.

Growth in International Investments

The cannabis venture scene is no longer just anchored in North America. In the past twelve months, European and Latin American markets have experienced a wave of VC interest, triggered by shifting regulations and high-growth medical markets. Investors are following new legalization pushes—especially in Germany, Portugal, and Colombia—where early-stage companies can scale with modest capital compared to the U.S. That said, cross-border hurdles remain a puzzle: from banking limitations to export restrictions, international cannabis deals demand both local know-how and patience.

Convergence with Psychedelics and Wellness

Wellness-driven investing is blurring industry boundaries. Cannabis VCs are starting to back startups working at the intersection of cannabinoids, functional mushrooms, and psychedelics, anticipating a broader shift toward plant-based therapeutics. Firms that once focused solely on THC or CBD are exploring ventures centered on psilocybin, ketamine therapy, and adaptogen-infused products. As clinical research grows and stigma erodes, this convergence is poised to reshape deal flow and investor interest, with wellness portfolios spanning far beyond the cannabis flower.

Technology and Sustainability Opportunities

Venture dollars in cannabis increasingly flow toward software, automation, and sustainable cultivation. AI-powered compliance, vertical farming, environmentally friendly packaging, and safe, solventless extraction methods are catching eyes. Investors want to see ventures that chip away at waste, reduce energy and water use, and meet emerging ESG standards. Startups leveraging data-driven solutions for supply chain transparency or sustainable practices are outpacing competitors stuck in analog systems.

As the cannabis industry evolves, so do the expectations and strategies of venture investors. These emerging trends are more than fleeting—they signal where future funding, competition, and partnerships will bloom. With this landscape in mind, entrepreneurs need to be sharper than ever when seeking the right partnership for their next fundraise.

Finding the Right Cannabis Venture Capital Partner

Attracting venture capital is about more than landing a check—it’s about choosing an ally who understands the cannabis industry’s rollercoaster landscape. The right partner doesn’t just write funding rounds; they bring connections, strategic insight, and operational support tailored for this still-maturing market.

Questions to Ask Potential VC Firms

Before you commit, dig deeper than the fund size or number of portfolio companies. Ask potential investors how they’re handling shifting regulations and what support they’ll provide if your operations face compliance hiccups. Do they have board seats in existing cannabis companies? Who are their reference founders? Find out what kind of mentorship they offer, how actively they participate day-to-day, and what their exit strategies look like in this sector. The more specific your questions, the clearer the fit.

How to Evaluate Fund Reputation and Track Record

In a sector sometimes clouded by hype, results matter. Beyond their logo wall, ask about past investments that resemble your growth stage and region. Are their portfolio companies scaling or sitting idle? Look for hard metrics, like follow-on financing rates or successful exits in tightly regulated markets. Seek feedback from founders in their portfolio—did promises around resources, network introductions, or crisis help match reality? Reputation travels fast in cannabis; off-the-record opinions are often the most telling.

Finding the right capital partner means thinking like a detective and a matchmaker. Once you’ve zeroed in on a shortlist, it’s time to prepare an irresistible pitch and anticipate the tough questions investors want answered.

Find Investors with AI